Medical News

RSS

BSP receives European CE conformance mark for HyperQ AD-100 add-on system

BSP, which develops and commercializes advanced products for the non invasive, accurate diagnosis of heart diseases, announced today that its Add-On product, the HyperQ AD-100, intended for improved diagnostic performance of Stress ECG, has been granted the European CE conformance mark.

30 Jun 2010

Ambulance services to improve in Victoria promises Health Minister

With increasing concern over ambulance services Health Minister Daniel Andrews has admitted that there are gaps in Victoria’s ambulance services and once new paramedics arrive the problem will be addressed under the government's regional ambulance policy.

29 Jun 2010

Rise in hospital admissions over last five years

According to a new ‘State of Our Public Hospitals’ report there is a 17 percent hike in the number of people seeking treatment at Australian hospitals in the last five years. This report was released by Health Minister Nicola Roxon on Tuesday.

29 Jun 2010

Alcohol during pregnancy affects fertility of unborn son: Study

According to new research a mother drinking alcohol during pregnancy can significantly affect the fertility of her unborn male offspring. The Danish study involved 347 young men aged 18 to 21 and found that those whose mothers had drunk more than four drinks a week during pregnancy had one third the sperm levels compared to those whose mothers were teetotalers.

29 Jun 2010

Importance of cell-cell communication in ischaemia

A team from the Bristol Heart Institute have investigated the importance of cell-cell communication in regulating the formation of new blood vessels following the restriction in blood supply to the heart or back leg in mice.

29 Jun 2010

Novel method of encapsulating gases, liquids and solids using miniature bubbles

Researchers from University College London have won a £25,000 prize for developing technology that could be used to improve medical imaging, the targeted delivery of drugs and much more.

29 Jun 2010

An innovative genetic prediction algorithm

A University of Toledo doctoral candidate in biomedical sciences recently combined the inspiration he received from his grandfather, values learned from his mother, insights gleaned from his mentors and processing power tapped from a supercomputer to unlock a few of the many secrets of the human genome.

29 Jun 2010

USPTO grants Vermillion Alzheimer's disease biomarker patent

Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Biomarkers for Alzheimer's disease" to the Company.

29 Jun 2010

Threshold Pharmaceuticals commences TH-302 Phase 1 clinical trial in patients with advanced leukemias

Threshold Pharmaceuticals, Inc., today announced that it has initiated a Phase 1 clinical trial of TH-302 in patients with advanced leukemias. TH-302 is a proprietary Hypoxia-Activated Prodrug (HAP) that specifically targets tumor hypoxia.

29 Jun 2010

Siemens Radiation Reduction Alliance launched

In a continual commitment to patient care and radiation reduction in computed tomography (CT), Siemens Healthcare has launched SIERRA (Siemens Radiation Reduction Alliance) and has established an expert panel to advance the cause of dose reduction in CT. The new Low Dose Expert Panel includes 15 specialists in radiology, cardiology and physics, who are internationally recognized for their publications on the subject of CT dose.

29 Jun 2010

Sparton added to Russell Microcap Index

Sparton Corporation announced that it has joined the Russell Microcap® Index according to the list posted June 28, 2010 on www.russell.com.

29 Jun 2010

Omnicell's OmniCenter qualifies for VMware Ready logo

Omnicell, Inc., a leading provider of system solutions to acute healthcare facilities, today announced that its OmniCenter® server has achieved VMware Ready™ status. This designation indicates that OmniCenter has passed a detailed evaluation and testing process managed by VMware and is now listed on the VMware Partner Product Catalog.

From Omnicell, Inc. 29 Jun 2010

Claros point-of-care system for PSA receives European CE Mark approval

Claros Diagnostics, a developer of novel point-of-care in vitro diagnostic systems, today announced the CE Mark approval for its rapid quantitative point-of-care diagnostic platform, which can now be used for prostate specific antigen (PSA) testing throughout the European Union. The approved system consists of a small portable analyzer and credit card-sized disposable.

29 Jun 2010

Arizona Integrated Physicians to implement eClinicalWorks unified EMR/PM system

eClinicalWorks®, a market leader in ambulatory clinical systems, today announced that Arizona Integrated Physicians (AIP), a physician-owned organization, has chosen eClinicalWorks unified electronic medical records (EMR) and practice management (PM) system for its approximately 600 physicians.

29 Jun 2010

Alnylam receives Portuguese, Swedish, British approvals to initiate ALN-TTR01 Phase I study in ATTR

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that its applications for ALN-TTR01 have been given clearance by Portuguese, Swedish, and British regulatory authorities to begin clinical testing. The trial will begin enrolling patients shortly in a blinded, randomized, placebo-controlled, multicenter Phase I study.

29 Jun 2010

Zymeworks closes $3.2 million financing round

Zymeworks Inc., a privately held biotechnology company focused on the development of next generation antibody-based therapeutics, today announced the close of a financing totaling $3.2 million. The financing consists of a follow-on round of institutional investment by CTI Life Sciences Fund, L.P. ("CTI") which led the Company's previous financing in 2009.

29 Jun 2010

Alimera submits Iluvien NDA for DME to FDA

Alimera Sciences, Inc.,, a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Iluvien®, (flucocinolone acetonide intravitreal insert), its investigational, sustained drug delivery system releasing sub-microgram levels of fluocinolone acetonide for the treatment of diabetic macular edema (DME).

29 Jun 2010

Prospect Medical Holdings added to Russell 2000 Index

Prospect Medical Holdings, Inc. today announced that it has been added to the list of public companies that comprise the Russell 2000® Index. In addition, Prospect was added to the Russell Global Index.

29 Jun 2010

BBD reports analyze effectiveness and safety of statin use

A series of new reports from Consumer Reports Best Buy Drugs (BBD) caution that the benefits of statin use by children and some women may not outweigh the risks. Drugs to lower cholesterol - including statins - are the most commonly prescribed drugs in the U.S. and garnered more than $14 billion in sales last year.

29 Jun 2010

Individual cells react differently to complex signals: Study

Using new technology that allows scientists to monitor how individual cells react in the complex system of cell signaling, Stanford University researchers have uncovered a much larger spectrum of differences between each cell than ever seen before.

29 Jun 2010